Growth Metrics

Boston Scientific (BSX) Other Non Operating Income (2016 - 2026)

Boston Scientific's Other Non Operating Income history spans 18 years, with the latest figure at $151.0 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 230.17% to $151.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $216.0 million, a 140.0% increase, with the full-year FY2025 number at -$228.0 million, down 1325.0% from a year prior.
  • Other Non Operating Income hit $151.0 million in Q1 2026 for Boston Scientific, up from -$125.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for BSX hit a ceiling of $215.0 million in Q4 2024 and a floor of -$412.0 million in Q4 2022.
  • Historically, Other Non Operating Income has averaged -$21.4 million across 5 years, with a median of -$23.0 million in 2024.
  • Biggest five-year swings in Other Non Operating Income: tumbled 1684.62% in 2022 and later soared 1533.33% in 2024.
  • Tracing BSX's Other Non Operating Income over 5 years: stood at -$412.0 million in 2022, then skyrocketed by 96.36% to -$15.0 million in 2023, then surged by 1533.33% to $215.0 million in 2024, then crashed by 158.14% to -$125.0 million in 2025, then surged by 220.8% to $151.0 million in 2026.
  • Business Quant data shows Other Non Operating Income for BSX at $151.0 million in Q1 2026, -$125.0 million in Q4 2025, and -$23.0 million in Q3 2025.